Examples of using Kaplan-meier in English and their translations into Norwegian
{-}
-
Colloquial
-
Ecclesiastic
-
Ecclesiastic
-
Computer
Figure 1: Kaplan-Meier curve for progression-free survival by independent assessment for the overall population(treatment-naïve
Figur 1: Kaplan-Meier kurve for progresjonsfri overlevelse ved uavhengig vurdering for hele populasjonen(behandlingsnaïveThe Kaplan-Meier median CR duration for the single institution study is 14 months and has not been reached for the multicentre study.
Kaplan-Meier median CR-varighet for enkeltsenterstudien er 14 måneder og ikke er oppnådd for multisenterstudien.Figure 1 BOLERO-2 Kaplan-Meier progression-free survival curves investigator radiological review.
Figur 1 BOLERO-2- Kaplan-Meier kurver: Progresjonsfri overlevelse utprøver radiologisk oversikt.Figure 1 Kaplan-Meier curve of Investigator assessed progression-free survival from Stage 1a.
Figur 1 Kaplan-Meier kurve for utprøver-vurdert progresjonsfri overlevelse fra trinn 1a.Figure 1 Kaplan-meier curve of IRC-assessed progression-free survival.
Figur 1 Kaplan-Meier kurve for IRC-vurdert progresjonsfri overlevelse.Figure 1 Kaplan-Meier overall survival curve, IMPACT study.
Figur 1 Kaplan-Meier kurve av totaloverlevelse, IMPACT-studie.Figure 1 Kaplan-Meier overall survival curves for Study MEK115306 ITT population.
Figur 1 Kaplan-Meier total overlevelseskurve for studie MEK115306 ITT populasjon.Figure 2 Kaplan-meier curve of overall survival.
Figur 2 Kaplan-Meier kurve for total overlevelse.Figure 2 Kaplan-Meier curve of overall survival from Stage 1a.
Figur 2 Kaplan-Meier kurve for total overlevelse fra trinn 1a.Figure 2: Kaplan-Meier curves Updated OS analysis for Study MEK116513.
Figur 2 Kaplan-Meier kurver oppdatert OS analyse for studie MEK116513.Figure 4 Kaplan-Meier curve of IRC-assessed progression-free survival in patients with follicular lymphoma.
Figur 4 Kaplan-Meier kurve for IRC-vurdert progresjonsfri overlevelse hos pasienter med follikulært lymfom.Figure 5 Kaplan-Meier curve of overall survival in patients with follicular lymphoma.
Figur 5 Kaplan-Meier kurve for total overlevelse hos pasienter med follikulært lymfom.Kaplan-Meier curve of progression-free survival by independent assessment for the overall population.
Kaplan-Meier kurve for progresjonsfri overlevelse ved uavhengig vurdering for den foregående sunitinib-subgruppen.Kaplan-Meier Estimate of Median Time to Event Months.
Kaplan-Meier estimat av median-tid for hendelse måneder.Kaplan-Meier Estimate of Median Time to Event Months.
Kaplan-Meier estimat Median tid til hendelse måneder.Kaplan-Meier estimate, months a.
Kaplan-Meier estimat, månedera.Kaplan-Meier medians Afinitor:
Kaplan-Meier medianer Afinitor:Kaplan-Meier medians Everolimus: 4.90 months.
Kaplan-Meier medianer Everolimus: 4,90 måneder.Figure 2 RADIANT-3- Kaplan-Meier progression-free survival curves investigator radiological review.
Figur 2 RADIANT-3- Kaplan-Meier kurver: Progresjonsfri overlevelse radiologisk vurdering av utprøver.Figure 2: Kaplan-Meier overall survival curves updated analysis.
Figur 2: Kaplan-Meier-kurver for total overlevelse oppdatert analyse.
